A microbial inoculant composition includes aquatic bacterial species. In some embodiments, the microbial inoculant composition includes at least one of an aquatic Pseudomonas spp. and a Clostridium spp.

A microbial inoculant composition includes aquatic bacterial species. In some embodiments, the microbial inoculant composition includes at least one of an aquatic Pseudomonas spp. and a Clostridium spp.

The present invention relates to a composition of effective biological control agents against eggs and/or larvae and/or pupae and/or adult insects' stages, with a broad-spectrum action. The invention is composed of sporulant entomopathogenic bacteria, entomopathogenic fungi, a limonoid, Efficient Microorganisms (EMs), a humic organic amendment in a liquid suspension, and a process for obtaining the composition.

The present invention relates to a composition of effective biological control agents against eggs and/or larvae and/or pupae and/or adult insects' stages, with a broad-spectrum action. The invention is composed of sporulant entomopathogenic bacteria, entomopathogenic fungi, a limonoid, Efficient Microorganisms (EMs), a humic organic amendment in a liquid suspension, and a process for obtaining the composition.

The present invention relates to a composition of effective biological control agents against eggs and/or larvae and/or pupae and/or adult insects' stages, with a broad-spectrum action. The invention is composed of sporulant entomopathogenic bacteria, entomopathogenic fungi, a limonoid, Efficient Microorganisms (EMs), a humic organic amendment in a liquid suspension, and a process for obtaining the composition.

A drug-containing capsule (20, 30, 40) includes a capsule material (21, 31, 41) and a drug (22, 32, 42) disposed within the capsule material (21, 31, 41) and having a sterilization action for a specific microorganism. The capsule material (21, 31, 41) includes a degradable part (21a, 31a, 41a) formed of a raw material that is caused to biodegrade by the specific microorganism. This results in suppression of release of the drug while the specific microorganism does not proliferate.

A drug-containing capsule (20, 30, 40) includes a capsule material (21, 31, 41) and a drug (22, 32, 42) disposed within the capsule material (21, 31, 41) and having a sterilization action for a specific microorganism. The capsule material (21, 31, 41) includes a degradable part (21a, 31a, 41a) formed of a raw material that is caused to biodegrade by the specific microorganism. This results in suppression of release of the drug while the specific microorganism does not proliferate.

Methods and compositions for making bacteriocins are described in some embodiments herein. In some embodiments, pro-polypeptide comprising the bacteriocins in the desired ratios in cis, and separated by cleavage sited can be produced by a microbial cell comprising a nucleic acid encoding the pro-polypeptide. In some embodiments microfluidic devices and methods for making specified mixtures of antimicrobial peptides and/or bacteriocins are described.

Methods and compositions for making bacteriocins are described in some embodiments herein. In some embodiments, pro-polypeptide comprising the bacteriocins in the desired ratios in cis, and separated by cleavage sited can be produced by a microbial cell comprising a nucleic acid encoding the pro-polypeptide. In some embodiments microfluidic devices and methods for making specified mixtures of antimicrobial peptides and/or bacteriocins are described.

A microbial inoculant composition including aquatic bacterial species. In some embodiments, the microbial inoculant composition includes at least one of an aquatic Pseudomonas spp. and a Clostridium spp.